HA
MRK icon

Huntleigh Advisors’s Merck MRK Stock Holding History

Huntleigh Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Buy
4,009
+51
+1% +$5.97K 0.07% 188
2026
Q1 		$476K Buy
3,958
+457
+13% +$52.8K 0.08% 182
2025
Q4 		$369K Sell
3,501
-122
-3% -$11.5K 0.06% 197
2025
Q3 		$304K Sell
3,623
-90
-2% -$7.41K 0.05% 214
2025
Q2 		$294K Sell
3,713
-18
-0.5% -$1.43K 0.06% 209
2025
Q1 		$335K Sell
3,731
-8,090
-68% -$755K 0.06% 182
2024
Q4 		$1.18M Buy
+11,821
New +$1.22M 0.25% 84

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Huntleigh Advisors's MRK Position: Q2 2026 in Review

Huntleigh Advisors increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $5.97K and bringing the position to 4,009 shares worth $515K. The position accounts for 0.07% of the portfolio, ranked #188.

Huntleigh Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18M in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Huntleigh Advisors held 4,009 shares of Merck worth $515K as of Q2 2026.
  • Huntleigh Advisors bought 51 Merck shares in Q2 2026, an estimated $5.97K.
  • Merck made up 0.07% of Huntleigh Advisors's portfolio in Q2 2026, its #188 holding.
  • Huntleigh Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Huntleigh Advisors's Merck position peaked at $1.18M in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.